2016
DOI: 10.7150/jca.13117
|View full text |Cite
|
Sign up to set email alerts
|

High Expression of the Newly Found Long Noncoding RNA Z38 Promotes Cell Proliferation and Oncogenic Activity in Breast Cancer

Abstract: The aberrant expression of long noncoding RNAs (lncRNAs) has great impacts on cancer origination and progression. In the current study, a newly found lncRNA Z38, which was identified through combining experiments of suppression subtractive hybridization (SSH) and reverse dot-blotting, was found to have high expression in breast cancer. More importantly, inhibiting Z38 expression by gene silencing greatly suppressed breast cancer cell proliferation and tumorigenesis, and treatment with Z38 siRNAs significantly … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
32
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(33 citation statements)
references
References 51 publications
1
32
0
Order By: Relevance
“…For example, lncRNA MALAT1 was upregulated in breast cancer and MALAT1 suppression inhibited cell proliferation, migration, and invasion, promoted apoptosis and cell cycle arrest in breast cancer . LncRNA Z38 was identified to be highly expressed and Z38 silencing significantly inhibited cell proliferation and tumorigenesis in breast cancer . Although great efforts have been made to elucidate the biological and mechanisms of lncRNAs in breast cancer, the pathogenesis of breast cancer is still unclear.…”
Section: Discussionsupporting
confidence: 52%
“…For example, lncRNA MALAT1 was upregulated in breast cancer and MALAT1 suppression inhibited cell proliferation, migration, and invasion, promoted apoptosis and cell cycle arrest in breast cancer . LncRNA Z38 was identified to be highly expressed and Z38 silencing significantly inhibited cell proliferation and tumorigenesis in breast cancer . Although great efforts have been made to elucidate the biological and mechanisms of lncRNAs in breast cancer, the pathogenesis of breast cancer is still unclear.…”
Section: Discussionsupporting
confidence: 52%
“…The testis, epididymis, sperm, and seminal extracellular vesicles were lysed in RIPA buffer (20 mM sodium phosphate, 150 mM NaCl, pH 7.4, 1% Nonidet P‐40, 0.11% SDS, and 0.5% deoxycholic acid) containing phenylmethylsulfonyl fluoride and protease inhibitor mixture (Roche, Switzerland). The total protein content in each sample was quantified using the Modified BCA Protein Assay kit (Sangon Biotech, China; Deng et al, ). Proteins were separated on SDS‐polyacrylamide gels and transferred to nitrocellulose membranes (Amersham Biosciences, Germany).…”
Section: Methodsmentioning
confidence: 99%
“…A novel lncRNA Z38 was found to have high expression in breast cancer [2]. Inhibition of lncRNA Z38 expression by gene silencing reported suppression of cell proliferation and tumorigenesis.…”
Section: Therapeutic Usementioning
confidence: 99%
“…Inhibition of lncRNA Z38 expression by gene silencing reported suppression of cell proliferation and tumorigenesis. Treatment with siRNAs has shown significant induction of apoptosis and inhibition of tumor growth indicating that Z38 can act as a therapeutic target and biomarker in carcinomas [2]. Similarly, knockdown of lncRNA Linc00974 is reported to inhibit the cell proliferation and invasion with activation of apoptosis and cell cycle arrest in hepatocellular carcinoma [4].…”
Section: Therapeutic Usementioning
confidence: 99%